Tetsutaro Hamano
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Losartan, uric acid, and cardiometabolic disease: beyond blood pressure control.
Journal: Hypertension research : official journal of the Japanese Society of Hypertension
Published: July 09, 2026
Trifluridine/tipiracil with or without bevacizumab in microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: A retrospective observational study.
Journal: Therapeutic advances in medical oncology
Published: March 21, 2026
Protocol of the IMPACT study: randomized, multicenter, phase 3 study evaluating the efficacy of immunotherapy (Atezolizumab) plus anti-VEGF therapy (Bevacizumab) in combination with transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma.
Journal: BMC cancer
Published: July 08, 2024
Clinical outcomes of intensive versus less intensive first-line chemotherapy for metastatic colorectal cancer.
Journal: Future oncology (London, England)
Published: June 30, 2023
Comparison of older and younger patients with ovarian cancer: A post hoc study (JGOG3016-A3) of the treatment strength and prognostic outcomes of conventional or dose-dense chemotherapy.
Journal: The journal of obstetrics and gynaecology research
Published: September 05, 2022
Real-World Evidence on Second-Line Treatment of Metastatic Colorectal Cancer Using Fluoropyrimidine, Irinotecan, and Angiogenesis Inhibitor.
Journal: Clinical colorectal cancer
Published: December 16, 2020
Identification of serum cytokine clusters associated with outcomes in ovarian clear cell carcinoma.
Journal: Scientific reports
Published: April 05, 2020
Effects of Anma therapy (Japanese massage) on health-related quality of life in gynecologic cancer survivors: A randomized controlled trial.
Journal: PloS one
Published: April 04, 2017
Randomized Phase III Trial of Irinotecan Plus Cisplatin Compared With Paclitaxel Plus Carboplatin As First-Line Chemotherapy for Ovarian Clear Cell Carcinoma: JGOG3017/GCIG Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 13, 2016
An open-label, randomized, phase II trial evaluating the efficacy and safety of standard of care with or without bevacizumab in platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer patients previously treated with bevacizumab for front-line or platinum-sensitive ovarian cancer: rationale, design, and methods of the Japanese Gynecologic Oncology Group study JGOG3023.
Journal: BMC cancer
Published: February 16, 2016
Last Updated: 09/26/2026